Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-24-084761

Chief Executive Officer sold 22,528 shares at $6.47 ($145,815)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tak Paul Peter Chief Executive Officer 2024-07-17 Sale −22,528 $6.47 $145,815 330,735 D
Open-market sales · 22,528 sh · avg $6.47 · $145,815
Loading xslF345X05/ownership.xml…